Elimination of an R-factor by trimethoprim
Pinney, R.J.; Smith, J.T.
Journal of Pharmacy and Pharmacology 24(Suppl): 126p
1972
ISSN/ISBN: 0022-3573 PMID: 4144845 Document Number: 50527
Document emailed within 1 workday
Related Documents
Kulpati, D.D.; Mayall, I.S.; Heera, H.S. 1984: A double-blind comparative study of trimethoprim versus trimethoprim-sulphamethaxazole combination in pneumonia Indian Journal of Chest Diseases and Allied Sciences 26(4): 225-229Männistö, P.T. 1976: Comparison of oxolinic acid, trimethoprim, and trimethoprim-sulfamethoxazole in the treatment and long-term control of urinary tract infection Current Therapeutic Research 20(5): 645-654
DuPont, H.L.; Galindo, E.; Evans, D.G.; Cabada, F.J.; Sullivan, P.; Evans, D.J. 1983: Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone Gastroenterology 84(1): 75-80
Anklesaria, P.; Paranjpe, S.; Gupta, K.; Acharya, V.; Paul, T.; Sheth, U.K. 1976: In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination Journal of Postgraduate Medicine 22(4): 171-175
Pérez, E.; Almirón, P.; Planas, M.J.; Llibre, C.; Santamaría, M.T.; Carbonell, M.; Boatella, L.; Viladot, A.; Lopeandía, L.; Torres, T.; Geis, S.; Martínez, R.; Caballero, M.J.; Llanas, E.; Navajas, P.; Rueda, C.; Gallardo, V.; Vendrell, D.; Valero, T.; Rambla, M.; Sepa, L. 1981: Hospital interference as a iatrogenic factor in the neonatal period. the function of nursing in its elimination Revista de Enfermeria 4(35-36): 19-25
Shenderov, B.A. 1972: Elimination of the R-factor and inhibition of episomic drug resistance in enteric bacteria by antihistaminics Biulleten' Eksperimental'noi Biologii i Meditsiny 73(6): 55-58
Danek, A.; Pogonowska-Wala, E. 1973: Studies on absorption and elimination of drugs. II. the kinetics of distribution and elimination of clorindion in the rabbit Polish Journal of Pharmacology and Pharmacy 25(3): 307-311
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Dharmshaktu, N.S.; Barkakaty, B.N.; Patnaik, P.K.; Arif, M.A. 1999: Progress towards elimination of leprosy as a public health problem in India and role of modified leprosy elimination campaign Leprosy Review 70(4): 430-439
Tomasevski, K. 1998: Les droits des femmes : de l'interdiction de la discrimination à son élimination - Women's rights : from the banning of discrimination to its elimination Revue Internationale des Sciences Sociales (158): 603-618
Tomasevski, K. 1998: Les droits des femmes : de l'interdiction de la discrimination à son élimination - Women's rights : from the banning of discrimination to its elimination Revue Internationale des Sciences Sociales (158): 603-618
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Hossain, M.; Broutet, N.; Hawkes, S. 2007: The elimination of congenital syphilis: a comparison of the proposed World Health Organization action plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies Sexually Transmitted Diseases 34(7 Suppl): S22-S30
Almus, F.E.; Rao, L.V.; Rapaport, S.I. 1989: Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells Thrombosis and Haemostasis 62(4): 1067-1073
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
Härkönen, M. 1993: Trimethoprim and liver Duodecim; Laaketieteellinen Aikakauskirja 109(9): 799
Brown, E.J.; Joiner, K.A.; Gaither, T.A.; Hammer, C.H.; Frank, M.M. 1983: The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system Journal of Immunology 131(1): 409-415
Sugihara, T.; Saito, H. 1987: Application of a monoclonal antibody against factor XIi (Hageman factor); enzyme-linked immunosorbent assay (ELISA) for factor XIi antigen Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(3): 691-695
Springer, C.; Eyal, F.; Michel, J. 1981: Cotrimoxazole (trimethoprim sulfamethoxazole) Harefuah 101(3-4): 80-84
Ristikankare, M.; Tarssanen, L. 1993: Trimethoprim-sulfadiazine-induced cholestasis Duodecim; Laaketieteellinen Aikakauskirja 109(2): 139-142